2025 Lysosomal Disease Summit Abstract Submission
In addition to keynote speakers and workshops, the Lysosomal Disease Summit program will feature research presentations from top-scoring abstracts submitted globally. All abstracts submitted on or before the 13 May 2025 (23:59 AEST) deadline will be reviewed by the Lysosomal Disease Summit Program Committee for oral and/or poster presentation, offering a unique opportunity for lysosomal disease scientists and professionals to share their innovative ideas and research.
First authors may return to the submission website to make changes to an abstract submission at any time before the deadline. Submissions may also be deleted at any time up to the deadline, if the abstract is no longer desired to be considered for presentation. AFTER 13 MAY 2025, ALL ABSTRACTS ARE CONSIDERED FINAL, NO CHANGES MAY BE MADE, AND ABSTRACTS MAY NOT BE WITHDRAWN.
The first author of the submitted abstract will be notified by 21 May 2025 if the abstract is accepted for oral or poster presentation.
It is important to note that the primary author is expected to present the abstract / poster at the Summit. Abstracts selected for oral presentation will receive a discounted registration rate.
A limited number of scholarships will be available in 2025. Click here for more information.
2025 Abstract Submissions Categories
The three (3) categories for 2025 abstract submissions are as follows:
- Basic or Translational Scientific Research:
Disease mechanisms, pathology, biomarkers, natural history, etc. - Clinical Applications:
including clinical trials and outcomes, case reports or case series - Social, Ethical and Legal Issues (SELI)/ Public health and policy:
Including newborn and population screening, AI, and machine learning
Abstract Requirements
Abstract Length
Abstracts are required to be no more than 500 words in length and may not contain images or figures.
Number of Authors
Abstract submissions may include no more than 25 authors. NO exceptions.
Disclosure Requirements
- ALL individuals listed as first authors will be required to submit a disclosure prior to the Lysosomal Disease Summit.
- Once an author finalizes their own disclosure, the same disclosure will be applied to ALL abstracts on which the individual is a listed author.
- More details will be sent to accepted authors on 21 May 2025.
First Authors
The first author will be designated to present the work for all submitted abstracts. Please ensure that the first author (first person listed by the submitter) is the person who will be presenting the abstract at the conference. Once submitted, abstracts may be edited or deleted until the deadline of 13 May 2025 (23:59 AEST); after the deadline, all submissions are considered final and may not be edited or withdrawn.
It is the policy of the Lysosomal Disease Summit to publish all abstracts with the list of authors exactly as the abstract was submitted to the Lysosomal Disease Summit. The first author of the submitted abstract will be listed as the presenting author on the Preliminary Program, Agenda, and/or Poster List. First authors cannot be changed once the listings are published or posted.
Abstract Selection
Abstracts will be selected through a blinded peer review process based on their scientific merit, originality, and relevance to lysosomal diseases. The program committee will determine their final placement in an oral platform or poster session.
Abstract Assignments
All abstracts submitted prior to the 13 May 2025 deadline will be reviewed by the Lysosomal Disease Summit Program Committee for oral or poster presentation. The first author of the submitted abstract will be notified of acceptance for oral or poster presentation by 21 May 2025. Information will also be posted here on the website as soon as it is available.
Meeting Registration
Note: Individuals who submit abstracts are not automatically registered for the Summit. In order to participate in the Summit as an oral or poster presenter, individuals must register for the meeting and also cover the costs of hotel and travel (if travel costs are applicable). Abstracts selected for oral presentation will receive a discounted registration rate of 50%. A non-transferable discount code will be included with the Abstract Acceptance Letter to oral presenters.
Abstracts must be submitted with the intention that they will be presented if selected.
Technical Support
If you have any questions regarding the abstract’s content, please contact . Due to varying time zones, please allow up to 24 hours for a response.